About Jieyi Biotechnology
Jieyi Biotechnology is a company based in Hangzhou (China) founded in 2019 by Wang Jun. Jieyi Biotechnology operates in a competitive market with competitors including Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
- Headquarter Hangzhou, China
- Founders Wang Jun
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Alibaba Group
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Jieyi Biotechnology
Investors in Jieyi Biotechnology
Jieyi Biotechnology has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Alibaba Group, Huatai Zijin Investment and Qianhai Ark Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Jieyi Biotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Jieyi Biotechnology
Investment portfolio details for Jieyi Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Jieyi Biotechnology
Detailed financials for Jieyi Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Jieyi Biotechnology Comparisons
Peer comparison for Jieyi Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Jieyi Biotechnology
Jieyi Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Food safety technologies are provided for pathogen identification.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Nucleic acid drugs are developed via RNA interference technology.
|
Detailed competitors of Jieyi Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jieyi Biotechnology
Complete news archive for Jieyi Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jieyi Biotechnology
Jieyi Biotechnology was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Jieyi Biotechnology is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.
Wang Jun is the current CEO of Jieyi Biotechnology. They have also founded this company.
Jieyi Biotechnology was founded in 2019 in Hangzhou, China, within the biotechnology sector. Sequencing-based diagnostic technology and platforms are developed by the company, including PDC-Seq for high-throughput nucleic acid sequencing of patient samples. Data analysis is conducted using a microbial genome database, clinical information, and software tools to identify pathogenic microorganisms and resistance genes. Operations focus on diagnostic applications for infectious diseases.
Jieyi Biotechnology's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
Jieyi Biotechnology has 6 investors. Key investors include Alibaba Group, Huatai Zijin Investment, Qianhai Ark Asset Management, Proxima Ventures, and CD Capital.